Abstract
A quantitative structure-activity relationship (QSAR) and molecular modeling study has been made on a series of hydroxyethylamine (HEA) derivatives acting as Beta-secretase inhibitors to find the physicochemical properties of the compounds governing their activity and nature of their interactions with the receptor. From this study it has been found that all three activities of HEA derivatives, i.e., enzyme inhibition, cell inhibition, and Cat-D inhibition activities, are primarily controlled by the molar refractivity of the compounds and that they have strong hydrogen bond interactions with the receptors. Using these results some new prospective compounds possessing higher potencies are predicted. The docking studies are performed on these compounds to see their mode of interaction with the receptor.
Letters in Drug Design & Discovery
Title:Design of Some New Potent Beta-secretase Inhibitors Based on QSAR and Molecular Modeling Study on a Series of Hydroxyethylamine Derivatives
Volume: 10 Issue: 3
Author(s): YashShree Pandey and Satya Prakash Gupta
Affiliation:
Abstract: A quantitative structure-activity relationship (QSAR) and molecular modeling study has been made on a series of hydroxyethylamine (HEA) derivatives acting as Beta-secretase inhibitors to find the physicochemical properties of the compounds governing their activity and nature of their interactions with the receptor. From this study it has been found that all three activities of HEA derivatives, i.e., enzyme inhibition, cell inhibition, and Cat-D inhibition activities, are primarily controlled by the molar refractivity of the compounds and that they have strong hydrogen bond interactions with the receptors. Using these results some new prospective compounds possessing higher potencies are predicted. The docking studies are performed on these compounds to see their mode of interaction with the receptor.
Export Options
About this article
Cite this article as:
Pandey YashShree and Prakash Gupta Satya, Design of Some New Potent Beta-secretase Inhibitors Based on QSAR and Molecular Modeling Study on a Series of Hydroxyethylamine Derivatives, Letters in Drug Design & Discovery 2013; 10 (3) . https://dx.doi.org/10.2174/1570180811310030009
DOI https://dx.doi.org/10.2174/1570180811310030009 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Humanin; A Defender Against Alzheimers Disease?
Recent Patents on CNS Drug Discovery (Discontinued) Leukocyte-mediated Tissue Injury in Ischemic Stroke
Current Medicinal Chemistry Conference Report: 183rd American Association for the Advancement of Science Annual Meeting, Boston MA, USA Feb 16-20, 2017: "Serving Society through Science Policy"
CNS & Neurological Disorders - Drug Targets Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System?
Current Pharmaceutical Design Sub-Chronic Exposure of Non-Observable Adverse Effect Dose of Terbufos Sulfone: Neuroinflammation in Diabetic and Non-Diabetic Rats
CNS & Neurological Disorders - Drug Targets Soy Isoflavone Alleviates Aβ1-42-Induced Impairment of Learning and Memory Ability Through the Regulation of RAGE/LRP-1 in Neuronal and Vascular Tissue
Current Neurovascular Research Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study
Current Neurovascular Research Altered Arginine Metabolism in Cells Transfected with Human Wild-Type Beta Amyloid Precursor Protein (βAPP)
Current Alzheimer Research Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Editorial (Hot Topic: Neurodegeneration: The First IBRO-Middle East Neuroscience Conference)
Current Alzheimer Research Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Nano-biotechnology and its Innovative Perspective in Diabetes Management
Mini-Reviews in Medicinal Chemistry Alzheimers Disease: Pathological Mechanisms and Recent Insights
Current Neuropharmacology Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
Current Pharmaceutical Design Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance
Current Molecular Medicine The Promise of Slow Down Ageing May Come from Curcumin
Current Pharmaceutical Design Dietary Lipids and Alzheimer’s Disease
Current Alzheimer Research